COVID-19 Severity and Stroke: Correlation of Imaging and Laboratory Markers
Jeffrey M. Katz(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Salman Azhar(Lenox Hill Hospital), Michele Gribko(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Christopher G. Filippi(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell), Jason J. Wang(Feinstein Institute for Medical Research), Pina C. Sanelli(Northwell Health), Ruben Kuzniecky(Northwell Health), Richard Libman(Long Island Jewish Medical Center), Souhel Najjar(North Shore University Hospital), Steven V. Pacia(Epilepsy Foundation), Avraham Zlochower(Donald & Barbara Zucker School of Medicine at Hofstra/Northwell)
Cited by 35
Related Papers
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial
|The Lancet|2013|1.2k
A developmental and genetic classification for malformations of cortical development: update 2012
|Brain|2012|1.1k
A developmental and genetic classification for malformations of cortical development
|Neurology|2005|720
Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study
|Brain|2017|546
Classification system for malformations of cortical development
|Neurology|2001|537